In January 2020, WHO released a rapid communication on use of molecular assays as initial tests for diagnosis of tuberculosis, recommending Truenat as a replacement for smear microscopy in TB diagnosis. This study was designed to assess perceived ease of use of Truenat among Laboratory staff as a new diagnostic tool for TB in Nigeria. This study used a cross-sectional design.
View Article and Find Full Text PDFBackground: The dispersible fixed-dose combination drug has been recommended as the mainstay of treatment for TB in children. However, more needs to be known about its effect on treatment. This study aimed to assess the effectiveness of the formulation on treatment adherence among children with TB.
View Article and Find Full Text PDFObjectives: This study aimed to assess the practices of private practitioners regarding tuberculosis (TB), and to ascertain factors related to the low contribution of private healthcare providers to TB prevention and care in Nigeria.
Design: This is a mixed methods study comprising a quantitative retrospective review and qualitative study.
Setting: Private health facilities (HF) in Oyo State and the Federal Capital Territory (FCT), Nigeria.
Trans R Soc Trop Med Hyg
September 2021